Work

Additional file 2 of An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Year: 2021

Type: dataset

Abstract: Additional file 2. Independent Pathway Analysis details. This spreadsheet contains the data results from IPA.

Source: Figshare

DOI: 10.6084/m9.figshare.14168146

Authors: Stringer-Reasor, Erica M., May, Jori E., Olariu, Eva, Caterinicchia, Valerie, Yufeng Li, Dongquan Chen, Manna, Deborah L. Della, Rocque, Gabrielle B., Vaklavas, Christos, Falkson, Carla I., Lisle M. Nabell, Acosta, Edward P., Forero-Torres, Andres, Yang, Eddy S.

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4394444792

Cites:

Cited by:

Related to: 10